- Investing Ideas
- South Korean Pharmaceuticals & Biotech Sustainable Track Record
South Korean Pharmaceuticals & Biotech Sustainable Track Record
Results
6
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
6 companies
PharmaResearch
Market Cap: ₩4.2t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩425,500.00
7D
7.9%
1Y
-37.8%
Samsung BiologicsLtd
Market Cap: ₩71.7t
Together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.
A207940
₩1,556,000.00
7D
2.8%
1Y
-2.0%
Oscotec
Market Cap: ₩1.5t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩38,300.00
7D
8.3%
1Y
11.0%
JW Shinyak
Market Cap: ₩129.9b
Engages in the research, development, production, and sale of medicines and medical supplies in South Korea.
A067290
₩2,150.00
7D
-7.7%
1Y
42.9%
JW Holdings
Market Cap: ₩289.2b
Operates as a healthcare company in South Korea, the United States, Japan, China, and internationally.
A096760
₩4,045.00
7D
6.2%
1Y
18.3%
SK Biopharmaceuticals
Market Cap: ₩6.9t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩87,500.00
7D
4.8%
1Y
-13.0%